Attached files
file | filename |
---|---|
10-K - Shengtai Pharmaceutical, Inc. | v197503_10k.htm |
EX-32.1 - Shengtai Pharmaceutical, Inc. | v197503_ex32-1.htm |
EX-23.1 - Shengtai Pharmaceutical, Inc. | v197503_ex23-1.htm |
EX-31.1 - Shengtai Pharmaceutical, Inc. | v197503_ex31-1.htm |
EX-31.2 - Shengtai Pharmaceutical, Inc. | v197503_ex31-2.htm |
EX-23.2 - Shengtai Pharmaceutical, Inc. | v197503_ex23-2.htm |
EXHIBIT
32.2
CERTIFICATION
OF CHIEF FINANCIAL OFFICER
PURSUANT
TO SECTION 18 U.S.C SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Shengtai Pharmaceutical, Inc., the
“Company,” on Form 10-K for the fiscal year ended June 30, 2010 as filed with
the Securities and Exchange Commission on the date hereof, the “Report,” I, Hu
Ye, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d), of the
Securities Exchange Act of 1934; and
2. That
the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
Date:
September 28, 2010
SHENGTAI
PHARMACEUTICAL, INC.
|
|
/s/ Hu Ye
|
|
Hu
Ye
|
|
Chief
Financial Officer
|